Aduro Biotech (ADRO) IPO Opens Up 88%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Aduro Biotech (ADRO) Sees IPO Price of $17/Share
April 14, 2015 10:13 AM EDTAduro Biotech, Inc. (Nasdaq: ADRO) filed an amended registration with the U.S. SEC for an IPO of its Common Stock. The company plans to offer 7 million common shares and sees an offering price of $17 per share. The company plans to list on... More
